SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'H1N'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XBB_A_STIA1_1 (TYROSINE-PROTEIN KINASE SYK)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	5 / 9	VAL A 142 ALA A 155 GLY A 236 PRO A 237 LEU A 282	H1N A 501 (-4.4A) H1N A 501 (-3.4A) H1N A 501 (-3.6A) H1N A 501 ( 4.5A) H1N A 501 (-4.8A)	0.39A	1xbbA-6ccfA: 19.6	1xbbA-6ccfA: 14.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XKK_A_FMMA91_2 (EPIDERMAL GROWTH FACTOR RECEPTOR)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	5 / 9	VAL A 142 LYS A 157 LEU A 214 LEU A 228 LEU A 232	H1N A 501 (-4.4A) H1N A 501 (-2.8A) None None H1N A 501 (-4.3A)	0.63A	1xkkA-6ccfA: 22.8	1xkkA-6ccfA: 14.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EUF_B_LQQB401_1 (CELL DIVISION PROTEIN KINASE 6)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	8 / 12	VAL A 142 LYS A 157 VAL A 212 PHE A 230 ASN A 280 LEU A 282 ALA A 292 ASP A 293	H1N A 501 (-4.4A) H1N A 501 (-2.8A) H1N A 501 (-4.9A) H1N A 501 (-3.7A) H1N A 501 (-4.5A) H1N A 501 (-4.8A) H1N A 501 ( 3.9A) H1N A 501 (-3.5A)	0.65A	2eufB-6ccfA: 26.3	2eufB-6ccfA: 15.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ITY_A_IREA2020_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	8 / 12	GLY A 135 VAL A 142 ALA A 155 LYS A 157 LEU A 228 GLY A 236 LEU A 282 ASP A 293	H1N A 501 ( 3.8A) H1N A 501 (-4.4A) H1N A 501 (-3.4A) H1N A 501 (-2.8A) None H1N A 501 (-3.6A) H1N A 501 (-4.8A) H1N A 501 (-3.5A)	0.72A	2ityA-6ccfA: 23.2	2ityA-6ccfA: 15.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2WGJ_A_VGHA2346_1 (HEPATOCYTE GROWTH FACTOR RECEPTOR)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	6 / 12	GLY A 135 VAL A 142 ALA A 155 GLY A 236 ALA A 292 ASP A 293	H1N A 501 ( 3.8A) H1N A 501 (-4.4A) H1N A 501 (-3.4A) H1N A 501 (-3.6A) H1N A 501 ( 3.9A) H1N A 501 (-3.5A)	0.47A	2wgjA-6ccfA: 23.3	2wgjA-6ccfA: 13.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_A_B49A1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	7 / 12	ILE A 134 VAL A 142 ALA A 155 PHE A 230 LEU A 232 GLY A 236 LEU A 282	H1N A 501 (-4.3A) H1N A 501 (-4.4A) H1N A 501 (-3.4A) H1N A 501 (-3.7A) H1N A 501 (-4.3A) H1N A 501 (-3.6A) H1N A 501 (-4.8A)	0.42A	2y7jA-6ccfA: 31.3	2y7jA-6ccfA: 14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_B_B49B1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	6 / 10	ILE A 134 VAL A 142 ALA A 155 PHE A 230 LEU A 232 ASP A 293	H1N A 501 (-4.3A) H1N A 501 (-4.4A) H1N A 501 (-3.4A) H1N A 501 (-3.7A) H1N A 501 (-4.3A) H1N A 501 (-3.5A)	0.60A	2y7jB-6ccfA: 31.2	2y7jB-6ccfA: 14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_B_B49B1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	7 / 10	ILE A 134 VAL A 142 ALA A 155 PHE A 230 LEU A 232 GLY A 236 LEU A 282	H1N A 501 (-4.3A) H1N A 501 (-4.4A) H1N A 501 (-3.4A) H1N A 501 (-3.7A) H1N A 501 (-4.3A) H1N A 501 (-3.6A) H1N A 501 (-4.8A)	0.43A	2y7jB-6ccfA: 31.2	2y7jB-6ccfA: 14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_C_B49C1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	7 / 10	ILE A 134 VAL A 142 ALA A 155 PHE A 230 LEU A 232 GLY A 236 LEU A 282	H1N A 501 (-4.3A) H1N A 501 (-4.4A) H1N A 501 (-3.4A) H1N A 501 (-3.7A) H1N A 501 (-4.3A) H1N A 501 (-3.6A) H1N A 501 (-4.8A)	0.45A	2y7jC-6ccfA: 27.6	2y7jC-6ccfA: 14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_D_B49D1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	7 / 10	ILE A 134 VAL A 142 ALA A 155 PHE A 230 LEU A 232 GLY A 236 LEU A 282	H1N A 501 (-4.3A) H1N A 501 (-4.4A) H1N A 501 (-3.4A) H1N A 501 (-3.7A) H1N A 501 (-4.3A) H1N A 501 (-3.6A) H1N A 501 (-4.8A)	0.43A	2y7jD-6ccfA: 31.0	2y7jD-6ccfA: 14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AOX_A_EMHA901_1 (ALK TYROSINE KINASE RECEPTOR)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	6 / 10	ALA A 155 LYS A 157 VAL A 212 LEU A 232 GLY A 236 LEU A 282	H1N A 501 (-3.4A) H1N A 501 (-2.8A) H1N A 501 (-4.9A) H1N A 501 (-4.3A) H1N A 501 (-3.6A) H1N A 501 (-4.8A)	0.55A	3aoxA-6ccfA: 22.0	3aoxA-6ccfA: 13.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BBT_B_FMMB91_1 (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	6 / 12	VAL A 142 ALA A 155 LEU A 214 LEU A 232 GLY A 236 LEU A 282	H1N A 501 (-4.4A) H1N A 501 (-3.4A) None H1N A 501 (-4.3A) H1N A 501 (-3.6A) H1N A 501 (-4.8A)	0.42A	3bbtB-6ccfA: 23.2	3bbtB-6ccfA: 13.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3CS9_A_NILA600_2 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	5 / 12	ALA A 155 GLY A 236 HIS A 273 LEU A 282 ALA A 292	H1N A 501 (-3.4A) H1N A 501 (-3.6A) None H1N A 501 (-4.8A) H1N A 501 ( 3.9A)	0.37A	3cs9A-6ccfA: 22.2	3cs9A-6ccfA: 14.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3FUP_B_MI1B1_1 (TYROSINE-PROTEIN KINASE JAK2)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	8 / 12	GLY A 135 GLY A 137 VAL A 142 ALA A 155 LYS A 157 VAL A 212 LEU A 233 LEU A 282	H1N A 501 ( 3.8A) None H1N A 501 (-4.4A) H1N A 501 (-3.4A) H1N A 501 (-2.8A) H1N A 501 (-4.9A) H1N A 501 (-4.6A) H1N A 501 (-4.8A)	0.55A	3fupB-6ccfA: 24.4	3fupB-6ccfA: 15.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3GCS_A_BAXA401_2 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	4 / 6	VAL A 211 LEU A 232 ILE A 271 ILE A 291	None H1N A 501 (-4.3A) None None	0.57A	3gcsA-6ccfA: 21.1	3gcsA-6ccfA: 12.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IK3_A_0LIA1_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	5 / 12	ALA A 155 VAL A 212 HIS A 273 LEU A 282 ALA A 292	H1N A 501 (-3.4A) H1N A 501 (-4.9A) None H1N A 501 (-4.8A) H1N A 501 ( 3.9A)	0.46A	3ik3A-6ccfA: 22.2	3ik3A-6ccfA: 13.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IK3_B_0LIB2_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	5 / 12	ALA A 155 VAL A 212 HIS A 273 LEU A 282 ALA A 292	H1N A 501 (-3.4A) H1N A 501 (-4.9A) None H1N A 501 (-4.8A) H1N A 501 ( 3.9A)	0.50A	3ik3B-6ccfA: 21.9	3ik3B-6ccfA: 13.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LFA_A_1N1A361_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	4 / 8	ALA A 155 LYS A 157 LEU A 228 LEU A 232	H1N A 501 (-3.4A) H1N A 501 (-2.8A) None H1N A 501 (-4.3A)	0.42A	3lfaA-6ccfA: 21.5	3lfaA-6ccfA: 11.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MIY_A_B49A1_1 (TYROSINE-PROTEIN KINASE ITK/TSK)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	7 / 11	ILE A 134 ALA A 155 LYS A 157 VAL A 212 PHE A 230 GLY A 236 LEU A 282	H1N A 501 (-4.3A) H1N A 501 (-3.4A) H1N A 501 (-2.8A) H1N A 501 (-4.9A) H1N A 501 (-3.7A) H1N A 501 (-3.6A) H1N A 501 (-4.8A)	0.58A	3miyA-6ccfA: 23.4	3miyA-6ccfA: 13.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MIY_B_B49B2_1 (TYROSINE-PROTEIN KINASE ITK/TSK)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	6 / 9	ILE A 134 ALA A 155 LYS A 157 PHE A 230 GLY A 236 LEU A 282	H1N A 501 (-4.3A) H1N A 501 (-3.4A) H1N A 501 (-2.8A) H1N A 501 (-3.7A) H1N A 501 (-3.6A) H1N A 501 (-4.8A)	0.57A	3miyB-6ccfA: 23.2	3miyB-6ccfA: 13.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OEZ_A_STIA601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	6 / 12	VAL A 142 ALA A 155 VAL A 212 GLY A 236 LEU A 282 ALA A 292	H1N A 501 (-4.4A) H1N A 501 (-3.4A) H1N A 501 (-4.9A) H1N A 501 (-3.6A) H1N A 501 (-4.8A) H1N A 501 ( 3.9A)	0.50A	3oezA-6ccfA: 7.2	3oezA-6ccfA: 14.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RGF_A_BAXA465_1 (CYCLIN-DEPENDENT KINASE 8)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	6 / 12	VAL A 142 ALA A 155 PHE A 230 LEU A 266 HIS A 273 ALA A 292	H1N A 501 (-4.4A) H1N A 501 (-3.4A) H1N A 501 (-3.7A) None None H1N A 501 ( 3.9A)	0.56A	3rgfA-6ccfA: 7.7	3rgfA-6ccfA: 14.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TI1_A_B49A299_1 (CYCLIN-DEPENDENT KINASE 2)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	5 / 9	ILE A 134 ALA A 155 VAL A 212 PHE A 230 LEU A 282	H1N A 501 (-4.3A) H1N A 501 (-3.4A) H1N A 501 (-4.9A) H1N A 501 (-3.7A) H1N A 501 (-4.8A)	0.59A	3ti1A-6ccfA: 24.2	3ti1A-6ccfA: 13.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UG2_A_IREA1_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	7 / 12	VAL A 142 ALA A 155 LYS A 157 LEU A 228 LEU A 232 GLY A 236 LEU A 282	H1N A 501 (-4.4A) H1N A 501 (-3.4A) H1N A 501 (-2.8A) None H1N A 501 (-4.3A) H1N A 501 (-3.6A) H1N A 501 (-4.8A)	0.57A	3ug2A-6ccfA: 23.4	3ug2A-6ccfA: 15.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	4 / 5	LYS A 157 VAL A 212 LEU A 282 ASP A 293	H1N A 501 (-2.8A) H1N A 501 (-4.9A) H1N A 501 (-4.8A) H1N A 501 (-3.5A)	1.10A	3wzdA-6ccfA: 6.3	3wzdA-6ccfA: 17.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZE_A_BAXA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	5 / 8	VAL A 211 VAL A 212 LEU A 282 ILE A 291 ASP A 293	None H1N A 501 (-4.9A) H1N A 501 (-4.8A) None H1N A 501 (-3.5A)	0.71A	3wzeA-6ccfA: 22.3	3wzeA-6ccfA: 17.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ZBF_A_VGHA3000_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ROS)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	5 / 12	ALA A 155 LEU A 232 GLY A 236 LEU A 282 ASP A 293	H1N A 501 (-3.4A) H1N A 501 (-4.3A) H1N A 501 (-3.6A) H1N A 501 (-4.8A) H1N A 501 (-3.5A)	0.43A	3zbfA-6ccfA: 12.9	3zbfA-6ccfA: 12.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ANQ_A_VGHA9000_1 (ALK TYROSINE KINASE RECEPTOR)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	6 / 9	VAL A 142 ALA A 155 GLY A 236 LEU A 282 ALA A 292 ASP A 293	H1N A 501 (-4.4A) H1N A 501 (-3.4A) H1N A 501 (-3.6A) H1N A 501 (-4.8A) H1N A 501 ( 3.9A) H1N A 501 (-3.5A)	0.55A	4anqA-6ccfA: 22.3	4anqA-6ccfA: 13.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ANS_A_VGHA9000_1 (ALK TYROSINE KINASE RECEPTOR)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	6 / 9	VAL A 142 ALA A 155 GLY A 236 LEU A 282 ALA A 292 ASP A 293	H1N A 501 (-4.4A) H1N A 501 (-3.4A) H1N A 501 (-3.6A) H1N A 501 (-4.8A) H1N A 501 ( 3.9A) H1N A 501 (-3.5A)	0.56A	4ansA-6ccfA: 22.3	4ansA-6ccfA: 13.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4I41_A_MIXA500_1 (SERINE/THREONINE-PRO TEIN KINASE PIM-1)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	7 / 12	VAL A 142 ALA A 155 ASP A 275 LYS A 277 ASN A 280 LEU A 282 ASP A 293	H1N A 501 (-4.4A) H1N A 501 (-3.4A) None None H1N A 501 (-4.5A) H1N A 501 (-4.8A) H1N A 501 (-3.5A)	0.63A	4i41A-6ccfA: 28.8	4i41A-6ccfA: 13.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KS8_A_B49A701_1 (SERINE/THREONINE-PRO TEIN KINASE PAK 6)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	6 / 10	ILE A 134 ALA A 155 VAL A 212 LEU A 233 GLY A 236 LEU A 282	H1N A 501 (-4.3A) H1N A 501 (-3.4A) H1N A 501 (-4.9A) H1N A 501 (-4.6A) H1N A 501 (-3.6A) H1N A 501 (-4.8A)	0.34A	4ks8A-6ccfA: 28.4	4ks8A-6ccfA: 15.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4MXY_B_DB8B601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	7 / 12	VAL A 142 ALA A 155 VAL A 212 GLY A 236 LEU A 282 ALA A 292 ASP A 293	H1N A 501 (-4.4A) H1N A 501 (-3.4A) H1N A 501 (-4.9A) H1N A 501 (-3.6A) H1N A 501 (-4.8A) H1N A 501 ( 3.9A) H1N A 501 (-3.5A)	0.58A	4mxyB-6ccfA: 23.8	4mxyB-6ccfA: 14.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4MXZ_B_DB8B601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	7 / 12	VAL A 142 ALA A 155 VAL A 212 GLY A 236 LEU A 282 ALA A 292 ASP A 293	H1N A 501 (-4.4A) H1N A 501 (-3.4A) H1N A 501 (-4.9A) H1N A 501 (-3.6A) H1N A 501 (-4.8A) H1N A 501 ( 3.9A) H1N A 501 (-3.5A)	0.58A	4mxzB-6ccfA: 23.8	4mxzB-6ccfA: 14.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OTW_A_DB8A1101_1 (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	7 / 12	VAL A 142 LYS A 157 VAL A 212 GLY A 236 LEU A 282 ALA A 292 ASP A 293	H1N A 501 (-4.4A) H1N A 501 (-2.8A) H1N A 501 (-4.9A) H1N A 501 (-3.6A) H1N A 501 (-4.8A) H1N A 501 ( 3.9A) H1N A 501 (-3.5A)	0.77A	4otwA-6ccfA: 23.1	4otwA-6ccfA: 18.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QMS_A_1N1A401_1 (SERINE/THREONINE-PRO TEIN KINASE 24)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	6 / 11	ILE A 134 ALA A 155 LYS A 157 LEU A 233 LEU A 282 ASP A 293	H1N A 501 (-4.3A) H1N A 501 (-3.4A) H1N A 501 (-2.8A) H1N A 501 (-4.6A) H1N A 501 (-4.8A) H1N A 501 (-3.5A)	0.68A	4qmsA-6ccfA: 28.9	4qmsA-6ccfA: 14.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QMZ_A_B49A401_1 (SERINE/THREONINE-PRO TEIN KINASE 24)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	6 / 12	ILE A 134 GLY A 135 VAL A 142 ALA A 155 LEU A 233 LEU A 282	H1N A 501 (-4.3A) H1N A 501 ( 3.8A) H1N A 501 (-4.4A) H1N A 501 (-3.4A) H1N A 501 (-4.6A) H1N A 501 (-4.8A)	0.35A	4qmzA-6ccfA: 28.6	4qmzA-6ccfA: 14.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RZ7_A_1E8A901_1 (CGMP-DEPENDENT PROTEIN KINASE, PUTATIVE)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	5 / 10	ILE A 134 ALA A 155 LYS A 157 LEU A 232 LEU A 282	H1N A 501 (-4.3A) H1N A 501 (-3.4A) H1N A 501 (-2.8A) H1N A 501 (-4.3A) H1N A 501 (-4.8A)	0.60A	4rz7A-6ccfA: 12.0	4rz7A-6ccfA: 7.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4TWP_A_AXIA601_1 (TYROSINE-PROTEIN KINASE ABL1)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	8 / 12	VAL A 142 ALA A 155 LYS A 157 GLY A 236 ASN A 280 LEU A 282 ALA A 292 ASP A 293	H1N A 501 (-4.4A) H1N A 501 (-3.4A) H1N A 501 (-2.8A) H1N A 501 (-3.6A) H1N A 501 (-4.5A) H1N A 501 (-4.8A) H1N A 501 ( 3.9A) H1N A 501 (-3.5A)	0.52A	4twpA-6ccfA: 24.7	4twpA-6ccfA: 13.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4U5J_A_RXTA601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	8 / 11	GLY A 137 VAL A 142 ALA A 155 GLY A 236 ASN A 280 LEU A 282 ALA A 292 ASP A 293	None H1N A 501 (-4.4A) H1N A 501 (-3.4A) H1N A 501 (-3.6A) H1N A 501 (-4.5A) H1N A 501 (-4.8A) H1N A 501 ( 3.9A) H1N A 501 (-3.5A)	0.51A	4u5jA-6ccfA: 24.8	4u5jA-6ccfA: 14.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4UXQ_A_0LIA1752_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 4)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	5 / 12	ALA A 155 LEU A 266 HIS A 273 LEU A 282 ALA A 292	H1N A 501 (-3.4A) None None H1N A 501 (-4.8A) H1N A 501 ( 3.9A)	0.37A	4uxqA-6ccfA: 22.1	4uxqA-6ccfA: 16.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4WKQ_A_IREA1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	6 / 12	ALA A 155 LYS A 157 LEU A 228 LEU A 232 GLY A 236 LEU A 282	H1N A 501 (-3.4A) H1N A 501 (-2.8A) None H1N A 501 (-4.3A) H1N A 501 (-3.6A) H1N A 501 (-4.8A)	0.34A	4wkqA-6ccfA: 24.0	4wkqA-6ccfA: 16.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XEY_B_1N1B601_1 (TYROSINE-PROTEIN KINASE ABL1)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	7 / 12	VAL A 142 ALA A 155 LYS A 157 VAL A 212 GLY A 236 LEU A 282 ALA A 292	H1N A 501 (-4.4A) H1N A 501 (-3.4A) H1N A 501 (-2.8A) H1N A 501 (-4.9A) H1N A 501 (-3.6A) H1N A 501 (-4.8A) H1N A 501 ( 3.9A)	0.64A	4xeyB-6ccfA: 24.1	4xeyB-6ccfA: 10.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	5 / 7	GLY A 135 GLY A 137 VAL A 142 LYS A 157 LEU A 159	H1N A 501 ( 3.8A) None H1N A 501 (-4.4A) H1N A 501 (-2.8A) None	0.44A	5izjA-6ccfA: 28.2	5izjA-6ccfA: 13.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	5 / 7	GLY A 135 GLY A 137 VAL A 142 LYS A 157 ASP A 293	H1N A 501 ( 3.8A) None H1N A 501 (-4.4A) H1N A 501 (-2.8A) H1N A 501 (-3.5A)	0.78A	5j5xA-6ccfA: 28.4	5j5xA-6ccfA: 13.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L2I_A_LQQA900_1 (CYCLIN-DEPENDENT KINASE 6)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	7 / 12	GLY A 135 TYR A 139 VAL A 142 ALA A 155 VAL A 212 LEU A 282 ALA A 292	H1N A 501 ( 3.8A) None H1N A 501 (-4.4A) H1N A 501 (-3.4A) H1N A 501 (-4.9A) H1N A 501 (-4.8A) H1N A 501 ( 3.9A)	0.70A	5l2iA-6ccfA: 8.3	5l2iA-6ccfA: 15.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L2I_A_LQQA900_1 (CYCLIN-DEPENDENT KINASE 6)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	7 / 12	GLY A 135 VAL A 142 ALA A 155 VAL A 212 PHE A 230 LEU A 282 ALA A 292	H1N A 501 ( 3.8A) H1N A 501 (-4.4A) H1N A 501 (-3.4A) H1N A 501 (-4.9A) H1N A 501 (-3.7A) H1N A 501 (-4.8A) H1N A 501 ( 3.9A)	0.63A	5l2iA-6ccfA: 8.3	5l2iA-6ccfA: 15.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L2T_A_6ZZA900_1 (CYCLIN-DEPENDENT KINASE 6)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	7 / 12	GLY A 135 VAL A 142 ALA A 155 VAL A 212 PHE A 230 LEU A 282 ALA A 292	H1N A 501 ( 3.8A) H1N A 501 (-4.4A) H1N A 501 (-3.4A) H1N A 501 (-4.9A) H1N A 501 (-3.7A) H1N A 501 (-4.8A) H1N A 501 ( 3.9A)	0.75A	5l2tA-6ccfA: 8.3	5l2tA-6ccfA: 15.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L2T_A_6ZZA900_1 (CYCLIN-DEPENDENT KINASE 6)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	7 / 12	ILE A 134 GLY A 135 VAL A 142 ALA A 155 VAL A 212 PHE A 230 LEU A 282	H1N A 501 (-4.3A) H1N A 501 ( 3.8A) H1N A 501 (-4.4A) H1N A 501 (-3.4A) H1N A 501 (-4.9A) H1N A 501 (-3.7A) H1N A 501 (-4.8A)	1.05A	5l2tA-6ccfA: 8.3	5l2tA-6ccfA: 15.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MO4_A_NILA601_2 (TYROSINE-PROTEIN KINASE ABL1)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	5 / 12	ALA A 155 VAL A 212 HIS A 273 LEU A 282 ALA A 292	H1N A 501 (-3.4A) H1N A 501 (-4.9A) None H1N A 501 (-4.8A) H1N A 501 ( 3.9A)	0.47A	5mo4A-6ccfA: 16.1	5mo4A-6ccfA: 11.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VCY_A_DB8A401_2 (MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	4 / 4	VAL A 212 LEU A 232 ASN A 280 ASP A 293	H1N A 501 (-4.9A) H1N A 501 (-4.3A) H1N A 501 (-4.5A) H1N A 501 (-3.5A)	0.92A	5vcyA-6ccfA: 24.4	5vcyA-6ccfA: 15.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XV7_A_EMHA705_1 (SERINE-ARGININE (SR) PROTEIN KINASE 1)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	5 / 12	GLY A 135 VAL A 142 ALA A 155 PHE A 230 ALA A 292	H1N A 501 ( 3.8A) H1N A 501 (-4.4A) H1N A 501 (-3.4A) H1N A 501 (-3.7A) H1N A 501 ( 3.9A)	0.30A	5xv7A-6ccfA: 25.1	5xv7A-6ccfA: 22.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Y9M_X_NIOX401_1 (CASEIN KINASE II SUBUNIT ALPHA')	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	4 / 8	VAL A 142 LYS A 157 PHE A 230 ASP A 293	H1N A 501 (-4.4A) H1N A 501 (-2.8A) H1N A 501 (-3.7A) H1N A 501 (-3.5A)	0.51A	5y9mX-6ccfA: 24.3	5y9mX-6ccfA: 23.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YF9_B_NIOB401_1 (CASEIN KINASE II SUBUNIT ALPHA')	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	4 / 7	VAL A 142 LYS A 157 PHE A 230 ASP A 293	H1N A 501 (-4.4A) H1N A 501 (-2.8A) H1N A 501 (-3.7A) H1N A 501 (-3.5A)	0.70A	5yf9B-6ccfA: 24.2	5yf9B-6ccfA: 23.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YU9_A_1E8A1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	6 / 12	GLY A 135 VAL A 142 ALA A 155 LYS A 157 LEU A 228 LEU A 282	H1N A 501 ( 3.8A) H1N A 501 (-4.4A) H1N A 501 (-3.4A) H1N A 501 (-2.8A) None H1N A 501 (-4.8A)	0.66A	5yu9A-6ccfA: 22.3	5yu9A-6ccfA: 23.96

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1XBB_A_STIA1_1","TYROSINE-PROTEIN KINASE SYK","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",5,"VAL A 142;ALA A 155;GLY A 236;PRO A 237;LEU A 282","H1N A 501 (-4.4A);H1N A 501 (-3.4A);H1N A 501 (-3.6A);H1N A 501 ( 4.5A);H1N A 501 (-4.8A)","0.39A","1xbbA-6ccfA:19.6",null],["1XKK_A_FMMA91_2","EPIDERMAL GROWTH FACTOR RECEPTOR","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",5,"VAL A 142;LYS A 157;LEU A 214;LEU A 228;LEU A 232","H1N A 501 (-4.4A);H1N A 501 (-2.8A);None;None;H1N A 501 (-4.3A)","0.63A","1xkkA-6ccfA:22.8","1xbbA-6ccfA:14.34"],["2EUF_B_LQQB401_1","CELL DIVISION PROTEIN KINASE 6","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",8,"VAL A 142;LYS A 157;VAL A 212;PHE A 230;ASN A 280;LEU A 282;ALA A 292;ASP A 293","H1N A 501 (-4.4A);H1N A 501 (-2.8A);H1N A 501 (-4.9A);H1N A 501 (-3.7A);H1N A 501 (-4.5A);H1N A 501 (-4.8A);H1N A 501 ( 3.9A);H1N A 501 (-3.5A)","0.65A","2eufB-6ccfA:26.3","1xkkA-6ccfA:14.90"],["2ITY_A_IREA2020_1","EPIDERMAL GROWTH FACTOR RECEPTOR","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",8,"GLY A 135;VAL A 142;ALA A 155;LYS A 157;LEU A 228;GLY A 236;LEU A 282;ASP A 293","H1N A 501 ( 3.8A);H1N A 501 (-4.4A);H1N A 501 (-3.4A);H1N A 501 (-2.8A);None;H1N A 501 (-3.6A);H1N A 501 (-4.8A);H1N A 501 (-3.5A)","0.72A","2ityA-6ccfA:23.2","2eufB-6ccfA:15.65"],["2WGJ_A_VGHA2346_1","HEPATOCYTE GROWTH FACTOR RECEPTOR","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",6,"GLY A 135;VAL A 142;ALA A 155;GLY A 236;ALA A 292;ASP A 293","H1N A 501 ( 3.8A);H1N A 501 (-4.4A);H1N A 501 (-3.4A);H1N A 501 (-3.6A);H1N A 501 ( 3.9A);H1N A 501 (-3.5A)","0.47A","2wgjA-6ccfA:23.3","2ityA-6ccfA:15.88"],["2Y7J_A_B49A1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",7,"ILE A 134;VAL A 142;ALA A 155;PHE A 230;LEU A 232;GLY A 236;LEU A 282","H1N A 501 (-4.3A);H1N A 501 (-4.4A);H1N A 501 (-3.4A);H1N A 501 (-3.7A);H1N A 501 (-4.3A);H1N A 501 (-3.6A);H1N A 501 (-4.8A)","0.42A","2y7jA-6ccfA:31.3","2wgjA-6ccfA:13.45"],["2Y7J_B_B49B1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",6,"ILE A 134;VAL A 142;ALA A 155;PHE A 230;LEU A 232;ASP A 293","H1N A 501 (-4.3A);H1N A 501 (-4.4A);H1N A 501 (-3.4A);H1N A 501 (-3.7A);H1N A 501 (-4.3A);H1N A 501 (-3.5A)","0.60A","2y7jB-6ccfA:31.2","2y7jA-6ccfA:14.29"],["2Y7J_B_B49B1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",7,"ILE A 134;VAL A 142;ALA A 155;PHE A 230;LEU A 232;GLY A 236;LEU A 282","H1N A 501 (-4.3A);H1N A 501 (-4.4A);H1N A 501 (-3.4A);H1N A 501 (-3.7A);H1N A 501 (-4.3A);H1N A 501 (-3.6A);H1N A 501 (-4.8A)","0.43A","2y7jB-6ccfA:31.2","2y7jB-6ccfA:14.29"],["2Y7J_C_B49C1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",7,"ILE A 134;VAL A 142;ALA A 155;PHE A 230;LEU A 232;GLY A 236;LEU A 282","H1N A 501 (-4.3A);H1N A 501 (-4.4A);H1N A 501 (-3.4A);H1N A 501 (-3.7A);H1N A 501 (-4.3A);H1N A 501 (-3.6A);H1N A 501 (-4.8A)","0.45A","2y7jC-6ccfA:27.6","2y7jB-6ccfA:14.29"],["2Y7J_D_B49D1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",7,"ILE A 134;VAL A 142;ALA A 155;PHE A 230;LEU A 232;GLY A 236;LEU A 282","H1N A 501 (-4.3A);H1N A 501 (-4.4A);H1N A 501 (-3.4A);H1N A 501 (-3.7A);H1N A 501 (-4.3A);H1N A 501 (-3.6A);H1N A 501 (-4.8A)","0.43A","2y7jD-6ccfA:31.0","2y7jC-6ccfA:14.29"],["3AOX_A_EMHA901_1","ALK TYROSINE KINASE RECEPTOR","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",6,"ALA A 155;LYS A 157;VAL A 212;LEU A 232;GLY A 236;LEU A 282","H1N A 501 (-3.4A);H1N A 501 (-2.8A);H1N A 501 (-4.9A);H1N A 501 (-4.3A);H1N A 501 (-3.6A);H1N A 501 (-4.8A)","0.55A","3aoxA-6ccfA:22.0","2y7jD-6ccfA:14.29"],["3BBT_B_FMMB91_1","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",6,"VAL A 142;ALA A 155;LEU A 214;LEU A 232;GLY A 236;LEU A 282","H1N A 501 (-4.4A);H1N A 501 (-3.4A);None;H1N A 501 (-4.3A);H1N A 501 (-3.6A);H1N A 501 (-4.8A)","0.42A","3bbtB-6ccfA:23.2","3aoxA-6ccfA:13.95"],["3CS9_A_NILA600_2","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",5,"ALA A 155;GLY A 236;HIS A 273;LEU A 282;ALA A 292","H1N A 501 (-3.4A);H1N A 501 (-3.6A);None;H1N A 501 (-4.8A);H1N A 501 ( 3.9A)","0.37A","3cs9A-6ccfA:22.2","3bbtB-6ccfA:13.98"],["3FUP_B_MI1B1_1","TYROSINE-PROTEIN KINASE JAK2","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",8,"GLY A 135;GLY A 137;VAL A 142;ALA A 155;LYS A 157;VAL A 212;LEU A 233;LEU A 282","H1N A 501 ( 3.8A);None;H1N A 501 (-4.4A);H1N A 501 (-3.4A);H1N A 501 (-2.8A);H1N A 501 (-4.9A);H1N A 501 (-4.6A);H1N A 501 (-4.8A)","0.55A","3fupB-6ccfA:24.4","3cs9A-6ccfA:14.13"],["3GCS_A_BAXA401_2","MITOGEN-ACTIVATED PROTEIN KINASE 14","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",4,"VAL A 211;LEU A 232;ILE A 271;ILE A 291","None;H1N A 501 (-4.3A);None;None","0.57A","3gcsA-6ccfA:21.1","3fupB-6ccfA:15.25"],["3IK3_A_0LIA1_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",5,"ALA A 155;VAL A 212;HIS A 273;LEU A 282;ALA A 292","H1N A 501 (-3.4A);H1N A 501 (-4.9A);None;H1N A 501 (-4.8A);H1N A 501 ( 3.9A)","0.46A","3ik3A-6ccfA:22.2","3gcsA-6ccfA:12.01"],["3IK3_B_0LIB2_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",5,"ALA A 155;VAL A 212;HIS A 273;LEU A 282;ALA A 292","H1N A 501 (-3.4A);H1N A 501 (-4.9A);None;H1N A 501 (-4.8A);H1N A 501 ( 3.9A)","0.50A","3ik3B-6ccfA:21.9","3ik3A-6ccfA:13.91"],["3LFA_A_1N1A361_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",4,"ALA A 155;LYS A 157;LEU A 228;LEU A 232","H1N A 501 (-3.4A);H1N A 501 (-2.8A);None;H1N A 501 (-4.3A)","0.42A","3lfaA-6ccfA:21.5","3ik3B-6ccfA:13.91"],["3MIY_A_B49A1_1","TYROSINE-PROTEIN KINASE ITK\/TSK","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",7,"ILE A 134;ALA A 155;LYS A 157;VAL A 212;PHE A 230;GLY A 236;LEU A 282","H1N A 501 (-4.3A);H1N A 501 (-3.4A);H1N A 501 (-2.8A);H1N A 501 (-4.9A);H1N A 501 (-3.7A);H1N A 501 (-3.6A);H1N A 501 (-4.8A)","0.58A","3miyA-6ccfA:23.4","3lfaA-6ccfA:11.17"],["3MIY_B_B49B2_1","TYROSINE-PROTEIN KINASE ITK\/TSK","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",6,"ILE A 134;ALA A 155;LYS A 157;PHE A 230;GLY A 236;LEU A 282","H1N A 501 (-4.3A);H1N A 501 (-3.4A);H1N A 501 (-2.8A);H1N A 501 (-3.7A);H1N A 501 (-3.6A);H1N A 501 (-4.8A)","0.57A","3miyB-6ccfA:23.2","3miyA-6ccfA:13.74"],["3OEZ_A_STIA601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",6,"VAL A 142;ALA A 155;VAL A 212;GLY A 236;LEU A 282;ALA A 292","H1N A 501 (-4.4A);H1N A 501 (-3.4A);H1N A 501 (-4.9A);H1N A 501 (-3.6A);H1N A 501 (-4.8A);H1N A 501 ( 3.9A)","0.50A","3oezA-6ccfA:7.2","3miyB-6ccfA:13.74"],["3RGF_A_BAXA465_1","CYCLIN-DEPENDENT KINASE 8","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",6,"VAL A 142;ALA A 155;PHE A 230;LEU A 266;HIS A 273;ALA A 292","H1N A 501 (-4.4A);H1N A 501 (-3.4A);H1N A 501 (-3.7A);None;None;H1N A 501 ( 3.9A)","0.56A","3rgfA-6ccfA:7.7","3oezA-6ccfA:14.34"],["3TI1_A_B49A299_1","CYCLIN-DEPENDENT KINASE 2","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",5,"ILE A 134;ALA A 155;VAL A 212;PHE A 230;LEU A 282","H1N A 501 (-4.3A);H1N A 501 (-3.4A);H1N A 501 (-4.9A);H1N A 501 (-3.7A);H1N A 501 (-4.8A)","0.59A","3ti1A-6ccfA:24.2","3rgfA-6ccfA:14.50"],["3UG2_A_IREA1_1","EPIDERMAL GROWTH FACTOR RECEPTOR","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",7,"VAL A 142;ALA A 155;LYS A 157;LEU A 228;LEU A 232;GLY A 236;LEU A 282","H1N A 501 (-4.4A);H1N A 501 (-3.4A);H1N A 501 (-2.8A);None;H1N A 501 (-4.3A);H1N A 501 (-3.6A);H1N A 501 (-4.8A)","0.57A","3ug2A-6ccfA:23.4","3ti1A-6ccfA:13.00"],["3WZD_A_LEVA1201_2","VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",4,"LYS A 157;VAL A 212;LEU A 282;ASP A 293","H1N A 501 (-2.8A);H1N A 501 (-4.9A);H1N A 501 (-4.8A);H1N A 501 (-3.5A)","1.10A","3wzdA-6ccfA:6.3","3ug2A-6ccfA:15.85"],["3WZE_A_BAXA1201_2","VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",5,"VAL A 211;VAL A 212;LEU A 282;ILE A 291;ASP A 293","None;H1N A 501 (-4.9A);H1N A 501 (-4.8A);None;H1N A 501 (-3.5A)","0.71A","3wzeA-6ccfA:22.3","3wzdA-6ccfA:17.08"],["3ZBF_A_VGHA3000_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ROS","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",5,"ALA A 155;LEU A 232;GLY A 236;LEU A 282;ASP A 293","H1N A 501 (-3.4A);H1N A 501 (-4.3A);H1N A 501 (-3.6A);H1N A 501 (-4.8A);H1N A 501 (-3.5A)","0.43A","3zbfA-6ccfA:12.9","3wzeA-6ccfA:17.08"],["4ANQ_A_VGHA9000_1","ALK TYROSINE KINASE RECEPTOR","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",6,"VAL A 142;ALA A 155;GLY A 236;LEU A 282;ALA A 292;ASP A 293","H1N A 501 (-4.4A);H1N A 501 (-3.4A);H1N A 501 (-3.6A);H1N A 501 (-4.8A);H1N A 501 ( 3.9A);H1N A 501 (-3.5A)","0.55A","4anqA-6ccfA:22.3","3zbfA-6ccfA:12.30"],["4ANS_A_VGHA9000_1","ALK TYROSINE KINASE RECEPTOR","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",6,"VAL A 142;ALA A 155;GLY A 236;LEU A 282;ALA A 292;ASP A 293","H1N A 501 (-4.4A);H1N A 501 (-3.4A);H1N A 501 (-3.6A);H1N A 501 (-4.8A);H1N A 501 ( 3.9A);H1N A 501 (-3.5A)","0.56A","4ansA-6ccfA:22.3","4anqA-6ccfA:13.16"],["4I41_A_MIXA500_1","SERINE\/THREONINE-PROTEIN KINASE PIM-1","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",7,"VAL A 142;ALA A 155;ASP A 275;LYS A 277;ASN A 280;LEU A 282;ASP A 293","H1N A 501 (-4.4A);H1N A 501 (-3.4A);None;None;H1N A 501 (-4.5A);H1N A 501 (-4.8A);H1N A 501 (-3.5A)","0.63A","4i41A-6ccfA:28.8","4ansA-6ccfA:13.16"],["4KS8_A_B49A701_1","SERINE\/THREONINE-PROTEIN KINASE PAK 6","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",6,"ILE A 134;ALA A 155;VAL A 212;LEU A 233;GLY A 236;LEU A 282","H1N A 501 (-4.3A);H1N A 501 (-3.4A);H1N A 501 (-4.9A);H1N A 501 (-4.6A);H1N A 501 (-3.6A);H1N A 501 (-4.8A)","0.34A","4ks8A-6ccfA:28.4","4i41A-6ccfA:13.41"],["4MXY_B_DB8B601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",7,"VAL A 142;ALA A 155;VAL A 212;GLY A 236;LEU A 282;ALA A 292;ASP A 293","H1N A 501 (-4.4A);H1N A 501 (-3.4A);H1N A 501 (-4.9A);H1N A 501 (-3.6A);H1N A 501 (-4.8A);H1N A 501 ( 3.9A);H1N A 501 (-3.5A)","0.58A","4mxyB-6ccfA:23.8","4ks8A-6ccfA:15.91"],["4MXZ_B_DB8B601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",7,"VAL A 142;ALA A 155;VAL A 212;GLY A 236;LEU A 282;ALA A 292;ASP A 293","H1N A 501 (-4.4A);H1N A 501 (-3.4A);H1N A 501 (-4.9A);H1N A 501 (-3.6A);H1N A 501 (-4.8A);H1N A 501 ( 3.9A);H1N A 501 (-3.5A)","0.58A","4mxzB-6ccfA:23.8","4mxyB-6ccfA:14.34"],["4OTW_A_DB8A1101_1","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",7,"VAL A 142;LYS A 157;VAL A 212;GLY A 236;LEU A 282;ALA A 292;ASP A 293","H1N A 501 (-4.4A);H1N A 501 (-2.8A);H1N A 501 (-4.9A);H1N A 501 (-3.6A);H1N A 501 (-4.8A);H1N A 501 ( 3.9A);H1N A 501 (-3.5A)","0.77A","4otwA-6ccfA:23.1","4mxzB-6ccfA:14.34"],["4QMS_A_1N1A401_1","SERINE\/THREONINE-PROTEIN KINASE 24","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",6,"ILE A 134;ALA A 155;LYS A 157;LEU A 233;LEU A 282;ASP A 293","H1N A 501 (-4.3A);H1N A 501 (-3.4A);H1N A 501 (-2.8A);H1N A 501 (-4.6A);H1N A 501 (-4.8A);H1N A 501 (-3.5A)","0.68A","4qmsA-6ccfA:28.9","4otwA-6ccfA:18.22"],["4QMZ_A_B49A401_1","SERINE\/THREONINE-PROTEIN KINASE 24","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",6,"ILE A 134;GLY A 135;VAL A 142;ALA A 155;LEU A 233;LEU A 282","H1N A 501 (-4.3A);H1N A 501 ( 3.8A);H1N A 501 (-4.4A);H1N A 501 (-3.4A);H1N A 501 (-4.6A);H1N A 501 (-4.8A)","0.35A","4qmzA-6ccfA:28.6","4qmsA-6ccfA:14.05"],["4RZ7_A_1E8A901_1","CGMP-DEPENDENT PROTEIN KINASE, PUTATIVE","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",5,"ILE A 134;ALA A 155;LYS A 157;LEU A 232;LEU A 282","H1N A 501 (-4.3A);H1N A 501 (-3.4A);H1N A 501 (-2.8A);H1N A 501 (-4.3A);H1N A 501 (-4.8A)","0.60A","4rz7A-6ccfA:12.0","4qmzA-6ccfA:14.05"],["4TWP_A_AXIA601_1","TYROSINE-PROTEIN KINASE ABL1","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",8,"VAL A 142;ALA A 155;LYS A 157;GLY A 236;ASN A 280;LEU A 282;ALA A 292;ASP A 293","H1N A 501 (-4.4A);H1N A 501 (-3.4A);H1N A 501 (-2.8A);H1N A 501 (-3.6A);H1N A 501 (-4.5A);H1N A 501 (-4.8A);H1N A 501 ( 3.9A);H1N A 501 (-3.5A)","0.52A","4twpA-6ccfA:24.7","4rz7A-6ccfA:7.23"],["4U5J_A_RXTA601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",8,"GLY A 137;VAL A 142;ALA A 155;GLY A 236;ASN A 280;LEU A 282;ALA A 292;ASP A 293","None;H1N A 501 (-4.4A);H1N A 501 (-3.4A);H1N A 501 (-3.6A);H1N A 501 (-4.5A);H1N A 501 (-4.8A);H1N A 501 ( 3.9A);H1N A 501 (-3.5A)","0.51A","4u5jA-6ccfA:24.8","4twpA-6ccfA:13.82"],["4UXQ_A_0LIA1752_1","FIBROBLAST GROWTH FACTOR RECEPTOR 4","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",5,"ALA A 155;LEU A 266;HIS A 273;LEU A 282;ALA A 292","H1N A 501 (-3.4A);None;None;H1N A 501 (-4.8A);H1N A 501 ( 3.9A)","0.37A","4uxqA-6ccfA:22.1","4u5jA-6ccfA:14.34"],["4WKQ_A_IREA1101_1","EPIDERMAL GROWTH FACTOR RECEPTOR","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",6,"ALA A 155;LYS A 157;LEU A 228;LEU A 232;GLY A 236;LEU A 282","H1N A 501 (-3.4A);H1N A 501 (-2.8A);None;H1N A 501 (-4.3A);H1N A 501 (-3.6A);H1N A 501 (-4.8A)","0.34A","4wkqA-6ccfA:24.0","4uxqA-6ccfA:16.90"],["4XEY_B_1N1B601_1","TYROSINE-PROTEIN KINASE ABL1","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",7,"VAL A 142;ALA A 155;LYS A 157;VAL A 212;GLY A 236;LEU A 282;ALA A 292","H1N A 501 (-4.4A);H1N A 501 (-3.4A);H1N A 501 (-2.8A);H1N A 501 (-4.9A);H1N A 501 (-3.6A);H1N A 501 (-4.8A);H1N A 501 ( 3.9A)","0.64A","4xeyB-6ccfA:24.1","4wkqA-6ccfA:16.07"],["5IZJ_G_AZ1G2_1","CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA;47P-AZ1-DAR-DAR","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",5,"GLY A 135;GLY A 137;VAL A 142;LYS A 157;LEU A 159","H1N A 501 ( 3.8A);None;H1N A 501 (-4.4A);H1N A 501 (-2.8A);None","0.44A","5izjA-6ccfA:28.2","4xeyB-6ccfA:10.34"],["5J5X_B_AZ1B2_1","CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA;47P-AZ1-DAL-DAR-DAR-DAR-DAR","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",5,"GLY A 135;GLY A 137;VAL A 142;LYS A 157;ASP A 293","H1N A 501 ( 3.8A);None;H1N A 501 (-4.4A);H1N A 501 (-2.8A);H1N A 501 (-3.5A)","0.78A","5j5xA-6ccfA:28.4","5izjA-6ccfA:13.76"],["5L2I_A_LQQA900_1","CYCLIN-DEPENDENT KINASE 6","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",7,"GLY A 135;TYR A 139;VAL A 142;ALA A 155;VAL A 212;LEU A 282;ALA A 292","H1N A 501 ( 3.8A);None;H1N A 501 (-4.4A);H1N A 501 (-3.4A);H1N A 501 (-4.9A);H1N A 501 (-4.8A);H1N A 501 ( 3.9A)","0.70A","5l2iA-6ccfA:8.3","5j5xA-6ccfA:13.76"],["5L2I_A_LQQA900_1","CYCLIN-DEPENDENT KINASE 6","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",7,"GLY A 135;VAL A 142;ALA A 155;VAL A 212;PHE A 230;LEU A 282;ALA A 292","H1N A 501 ( 3.8A);H1N A 501 (-4.4A);H1N A 501 (-3.4A);H1N A 501 (-4.9A);H1N A 501 (-3.7A);H1N A 501 (-4.8A);H1N A 501 ( 3.9A)","0.63A","5l2iA-6ccfA:8.3","5l2iA-6ccfA:15.65"],["5L2T_A_6ZZA900_1","CYCLIN-DEPENDENT KINASE 6","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",7,"GLY A 135;VAL A 142;ALA A 155;VAL A 212;PHE A 230;LEU A 282;ALA A 292","H1N A 501 ( 3.8A);H1N A 501 (-4.4A);H1N A 501 (-3.4A);H1N A 501 (-4.9A);H1N A 501 (-3.7A);H1N A 501 (-4.8A);H1N A 501 ( 3.9A)","0.75A","5l2tA-6ccfA:8.3","5l2iA-6ccfA:15.65"],["5L2T_A_6ZZA900_1","CYCLIN-DEPENDENT KINASE 6","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",7,"ILE A 134;GLY A 135;VAL A 142;ALA A 155;VAL A 212;PHE A 230;LEU A 282","H1N A 501 (-4.3A);H1N A 501 ( 3.8A);H1N A 501 (-4.4A);H1N A 501 (-3.4A);H1N A 501 (-4.9A);H1N A 501 (-3.7A);H1N A 501 (-4.8A)","1.05A","5l2tA-6ccfA:8.3","5l2tA-6ccfA:15.65"],["5MO4_A_NILA601_2","TYROSINE-PROTEIN KINASE ABL1","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",5,"ALA A 155;VAL A 212;HIS A 273;LEU A 282;ALA A 292","H1N A 501 (-3.4A);H1N A 501 (-4.9A);None;H1N A 501 (-4.8A);H1N A 501 ( 3.9A)","0.47A","5mo4A-6ccfA:16.1","5l2tA-6ccfA:15.65"],["5VCY_A_DB8A401_2","MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",4,"VAL A 212;LEU A 232;ASN A 280;ASP A 293","H1N A 501 (-4.9A);H1N A 501 (-4.3A);H1N A 501 (-4.5A);H1N A 501 (-3.5A)","0.92A","5vcyA-6ccfA:24.4","5mo4A-6ccfA:11.56"],["5XV7_A_EMHA705_1","SERINE-ARGININE (SR) PROTEIN KINASE 1","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",5,"GLY A 135;VAL A 142;ALA A 155;PHE A 230;ALA A 292","H1N A 501 ( 3.8A);H1N A 501 (-4.4A);H1N A 501 (-3.4A);H1N A 501 (-3.7A);H1N A 501 ( 3.9A)","0.30A","5xv7A-6ccfA:25.1","5vcyA-6ccfA:15.19"],["5Y9M_X_NIOX401_1","CASEIN KINASE II SUBUNIT ALPHA'","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",4,"VAL A 142;LYS A 157;PHE A 230;ASP A 293","H1N A 501 (-4.4A);H1N A 501 (-2.8A);H1N A 501 (-3.7A);H1N A 501 (-3.5A)","0.51A","5y9mX-6ccfA:24.3","5xv7A-6ccfA:22.11"],["5YF9_B_NIOB401_1","CASEIN KINASE II SUBUNIT ALPHA'","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",4,"VAL A 142;LYS A 157;PHE A 230;ASP A 293","H1N A 501 (-4.4A);H1N A 501 (-2.8A);H1N A 501 (-3.7A);H1N A 501 (-3.5A)","0.70A","5yf9B-6ccfA:24.2","5y9mX-6ccfA:23.53"],["5YU9_A_1E8A1101_1","EPIDERMAL GROWTH FACTOR RECEPTOR","6ccf","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1","Homo sapiens",6,"GLY A 135;VAL A 142;ALA A 155;LYS A 157;LEU A 228;LEU A 282","H1N A 501 ( 3.8A);H1N A 501 (-4.4A);H1N A 501 (-3.4A);H1N A 501 (-2.8A);None;H1N A 501 (-4.8A)","0.66A","5yu9A-6ccfA:22.3","5yf9B-6ccfA:23.53"]]